Scarica l'app Stockscreener
12.13
0.08%
0.01
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Cogent Biosciences Inc Borsa (COGT) Ultime notizie
Cogent Biosciences Inc. Inches Above Key Support — Safe to HoldIndex Update & Daily Growth Stock Investment Tips - thegnnews.com
Cogent Biosciences, Inc. $COGT Stock Position Lessened by XTX Topco Ltd - MarketBeat
Cogent Biosciences Inc. Price Targets Raised After ReboundJuly 2025 Technicals & Risk Controlled Swing Alerts - kangso.co.kr
Is Cogent Biosciences Inc. a good ESG investment2025 Volatility Report & Community Driven Trade Alerts - thegnnews.com
What makes Cogent Biosciences Inc. stock price move sharplyJuly 2025 Selloffs & Technical Confirmation Trade Alerts - Newser
Backtesting results for Cogent Biosciences Inc. trading strategiesRisk Management & Real-Time Buy Signal Alerts - Newser
Can volume confirm reversal in Cogent Biosciences Inc.Weekly Trade Review & Long-Term Safe Investment Plans - Newser
Live market analysis of Cogent Biosciences Inc.2025 Geopolitical Influence & Consistent Growth Equity Picks - Newser
Can technical indicators confirm Cogent Biosciences Inc.’s reversalJuly 2025 Action & Community Consensus Stock Picks - Newser
What machine learning models say about Cogent Biosciences Inc.2025 Earnings Surprises & Technical Pattern Recognition Alerts - Newser
How to build a custom watchlist for Cogent Biosciences Inc.2025 Analyst Calls & Consistent Profit Trading Strategies - Newser
When is the best time to buy Cogent Biosciences Inc. stockEarnings Overview Report & Safe Entry Point Identification - Newser
Real time breakdown of Cogent Biosciences Inc. stock performanceJuly 2025 Drop Watch & Daily Profit Maximizing Trade Tips - Newser
Is There Enough Volume to Lift Cogent Biosciences Inc.Rate Hike & Daily Chart Pattern Signal Reports - sundaytimes.kr
XTX Topco Ltd Cuts Stake in Cogent Biosciences, Inc. (NASDAQ:COGT) - Defense World
Using data filters to optimize entry into Cogent Biosciences Inc.2025 Price Action Summary & Free Long-Term Investment Growth Plans - Newser
Knott David M Jr Takes $1.28 Million Position in Cogent Biosciences, Inc. (NASDAQ:COGT) - MarketBeat
Drawdown in Cogent Biosciences Inc. May Be Nearing EndTrade Exit Summary & Daily Oversold Stock Bounce Ideas - kangso.co.kr
Do Rising R&D Losses at Cogent Biosciences (COGT) Reflect Strategic Vision or Escalating Risk? - simplywall.st
Resistance Break Could Fuel Cogent Biosciences Inc. Rally2025 Top Decliners & Verified Chart Pattern Trade Signals - beatles.ru
Wedbush Lowers Earnings Estimates for Cogent Biosciences - MarketBeat
Leerink Partnrs Has Pessimistic Outlook of COGT Q3 Earnings - MarketBeat
Cogent Biosciences Announces Participation in the Jefferies Global Healthcare Conference - The Globe and Mail
Cogent Biosciences Reports First Quarter 2025 Financial Results - The Globe and Mail
Cogent Biosciences Reports Recent Business Highlights and Fourth Quarter and Full Year 2024 Financial Results - The Globe and Mail
Cogent Biosciences Secures up to $400 Million in Non-Dilutive Financing - The Globe and Mail
Cogent Biosciences to Participate in the Guggenheim Biotech Conference - The Globe and Mail
Q3 EPS Forecast for Cogent Biosciences Raised by Analyst - MarketBeat
JPMorgan Chase & Co. Forecasts Strong Price Appreciation for Cogent Biosciences (NASDAQ:COGT) Stock - MarketBeat
Wedbush Reduces Earnings Estimates for Cogent Biosciences - MarketBeat
Cogent Biosciences price target lowered to $21 from $22 at H.C. Wainwright - MSN
Cogent Biosciences (NASDAQ:COGT) Price Target Raised to $30.00 - Defense World
HC Wainwright Issues Pessimistic Forecast for Cogent Biosciences (NASDAQ:COGT) Stock Price - MarketBeat
Cogent Biosciences (NASDAQ:COGT) Posts Quarterly Earnings Results, Beats Estimates By $0.02 EPS - MarketBeat
How Investors Are Reacting To Cogent Biosciences (COGT) Widening Losses in Q2 and First Half 2025 - simplywall.st
Leerink Partnrs Issues Negative Outlook for COGT Earnings - Defense World
Cogent Biosciences shares fall 1.64% intraday after Cogent Communications misses Q2 net loss per share estimates. - AInvest
Cogent Biosciences Reports Increased Losses Amidst Ongoing Development - The Globe and Mail
Cogent Biosciences Reports Positive Trial Results, Updates Financial Position - AInvest
Scotiabank Maintains Cogent Biosciences(COGT.US) With Buy Rating, Maintains Target Price $17 - 富途牛牛
Needham Maintains Cogent Biosciences(COGT.US) With Hold Rating - 富途牛牛
COGT Stock Rating Maintained by HC Wainwright, Price Target Lowe - GuruFocus
Cogent Biosciences (COGT) Price Target Revised by Analyst - GuruFocus
Decoding Cogent Biosciences Inc (COGT): A Strategic SWOT Insight - GuruFocus
Promising Pipeline and Financial Stability Drive Buy Rating for Cogent Biosciences - TipRanks
Cogent Biosciences: KDJ Golden Cross and Bullish Marubozu Indicators Detected - AInvest
Cogent Biosciences Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Cogent Biosciences Reports Recent Business Highlights and Secon - GuruFocus
Cogent Biosciences' Q2 net loss widens as costs mount - TradingView
Cogent Biosciences Reports Recent Business Highlights and Second Quarter 2025 Financial Results - GlobeNewswire
BRIEF-Cogent Biosciences Q2 Operating Expenses USD 75.581 Million - TradingView
0.39%
0.57%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):